Accretion Nutraveda Ltd

Accretion Nutraveda Ltd (ANL) is a micro-cap Healthcare company valued at ₹214 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move

Accretion Nutraveda Ltd last traded at ₹295, unchanged on the day.

Financial performance

The company's business is improving, with annual revenue rising 110.0% and net profit growing 102.8% year-on-year. The latest quarter saw revenue increase 80.1% and net profit rise 56.4% compared to the same quarter a year earlier, though the net profit margin narrowed slightly to 15.1% from 15.6%.

Valuation multiples

The stock trades at 42.1 times earnings, a premium to the Healthcare median of 32.0, 5.76 times book value.

Things to watch

The net profit margin has narrowed by 0.5 percentage points, and domestic institutional holding fell by 0.99 points in the quarter. The stock is 5.8% below its 52-week high, and the company's market cap remains at ₹214 crore, reflecting its micro-cap status.

Where it stands

The company has delivered strong revenue and profit growth over both the past year and the latest quarter, with revenue and profit growing at 126.5% and 162.6% CAGR over three years. The stock is currently 5.8% below its 52-week high, and the net profit margin has slightly declined.

Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.